News Quantified

TXG – 10x genomics, inc. (US:NASDAQ)

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease [Yahoo! Finance]

1/12

09:11 am

txg

Medium

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease

10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling

Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology

10x Genomics (NASDAQ:TXG) was given a new $21.00 price target on by analysts at Needham & Company LLC.

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}